These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28555585)

  • 1. Highlights from the 27th ECCMID.
    McConnell J; Sekkides O
    Lancet Infect Dis; 2017 Jun; 17(6):586-587. PubMed ID: 28555585
    [No Abstract]   [Full Text] [Related]  

  • 2. Infectious disease threats: what are we to do? Preface.
    Paauw DS
    Med Clin North Am; 2013 Jul; 97(4):xiii-xiv. PubMed ID: 23809724
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic vancomycin overexposure in a patient with spinal cord injury who had Staphylococcal sepsis and Clostridium difficile colitis.
    Pea F; Furlanut M; Bianchi L
    Ther Drug Monit; 2000 Apr; 22(2):233-4. PubMed ID: 10774640
    [No Abstract]   [Full Text] [Related]  

  • 4. Fatal bacteraemia and infective endocarditis due to meticillin-resistant Staphylococcus aureus (MRSA) with rapid emergence of rifampicin resistance during vancomycin/rifampicin combination treatment.
    Liu WL; Hung YL; Lin SH; Lee PI; Hsueh PR
    Int J Antimicrob Agents; 2010 Jun; 35(6):615-6. PubMed ID: 20236804
    [No Abstract]   [Full Text] [Related]  

  • 5. Pseudomembranous colitis and bacteremia in an immune competent patient associated with a rare specie of Clostridium (C. ramosum).
    Alcalde-Vargas A; Trigo-Salado C; Leo Carnerero E; De-la-Cruz-Ramírez D; Herrera-Justiniano JM
    Rev Esp Enferm Dig; 2012 Sep; 104(9):498-9. PubMed ID: 23130861
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnosis and therapy of staphylococcal enterocolitis].
    Chovancová A; Lucanský A
    Bratisl Lek Listy; 1970; 54(1):92-7. PubMed ID: 5456472
    [No Abstract]   [Full Text] [Related]  

  • 7. Pseudomembranous enterocolitis. A comparison with staphylococcal colitis.
    Strickler JH; Rice CO
    Minn Med; 1966 Jun; 49(6):899-904. PubMed ID: 5933702
    [No Abstract]   [Full Text] [Related]  

  • 8. Serious staphylococcal infections--cyclic lipopeptides: meeting new challenges.
    Graninger W
    Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():1-2. PubMed ID: 18226083
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful Use of High-dose Daptomycin in a Child With Staphylococcus aureus Endocarditis.
    Prabhudesai S; Kanjani A; Nambi PS; Gnanasambandam S; Ramachandran B
    Pediatr Infect Dis J; 2016 May; 35(5):517-8. PubMed ID: 27074655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin-Resistant Staphylococcus hemolyticus Bacteremia Treated Successfully by Intravenous Daptomycin and Catheter Removal in a Hemodialysis Patient.
    Hung YM; Wang JH; Wann SR
    Ther Apher Dial; 2015 Jun; 19(3):302. PubMed ID: 25530308
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin.
    Ahmad NM; Rojtman AD
    Ann Pharmacother; 2010 May; 44(5):918-21. PubMed ID: 20354160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Call for Greater Consideration for the Role of Vaccines in National Strategies to Combat Antibiotic-Resistant Bacteria: Recommendations from the National Vaccine Advisory Committee: Approved by the National Vaccine Advisory Committee on June 10, 2015.
    National Vaccine Advisory Committee
    Public Health Rep; 2016; 131(1):11-6. PubMed ID: 26843664
    [No Abstract]   [Full Text] [Related]  

  • 13. Linezolid resistance in three isolates of coagulase-negative staphylococci.
    Cieloszyk K; Amodio-Groton M; Saeed M; Coyle CM
    Ann Pharmacother; 2007 Mar; 41(3):526-7. PubMed ID: 17341527
    [No Abstract]   [Full Text] [Related]  

  • 14. Staphylococcus aureus bacteremia in hospitalized children: incidence and outcomes.
    Klieger SB; Vendetti ND; Fisher BT; Gerber JS
    Infect Control Hosp Epidemiol; 2015 May; 36(5):603-5. PubMed ID: 25880680
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on the global number of vancomycin-resistant Staphylococcus aureus (VRSA) strains.
    Moravvej Z; Estaji F; Askari E; Solhjou K; Naderi Nasab M; Saadat S
    Int J Antimicrob Agents; 2013 Oct; 42(4):370-1. PubMed ID: 23880172
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.
    Charles PG; Ward PB; Johnson PD; Howden BP; Grayson ML
    Clin Infect Dis; 2004 Feb; 38(3):448-51. PubMed ID: 14727222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRSA bacteraemia after caesarean section wound infection: when screening is missed and things go wrong.
    Melendez J; Claxton A; Erskine K
    Arch Gynecol Obstet; 2012 Mar; 285(3):663-5. PubMed ID: 21870068
    [No Abstract]   [Full Text] [Related]  

  • 18. Is the minimum inhibitory concentration of vancomycin an infallible predictor of the clinical outcome of Staphylococcus aureus bacteremia treated with vancomycin?
    Pea F; Viale P
    Clin Infect Dis; 2009 Aug; 49(4):642-3; author reply 643-5. PubMed ID: 19619048
    [No Abstract]   [Full Text] [Related]  

  • 19. Bacteraemia with rifampin-resistant Staphylococcus aureus and the potential role of cross-resistance between rifampin and rifaximin.
    Valentin T; Hoenigl M; Wagner J; Krause R; Zollner-Schwetz I
    J Infect; 2014 Sep; 69(3):295-7. PubMed ID: 24780764
    [No Abstract]   [Full Text] [Related]  

  • 20. The treatment triangle for staphylococcal infections.
    Grayson ML
    N Engl J Med; 2006 Aug; 355(7):724-7. PubMed ID: 16914709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.